Skip to main content
Equibles

DCF Advisers, LLC

Position in ZLAB — Zai Lab Ltd

CIK 1802493 MOUNT PLEASANT, SC
Back to ZLAB Full portfolio

Position in ZLAB

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$1,206,500
+$12,065 QoQ
Shares Held
63,500
0.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#43
of 92 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZLAB Over Time

Shares Held

Position Value (USD)

Derivatives in ZLAB

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$26,460
PutShares
1,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DCF Advisers, LLC holds $72,469,035 across 22 Biotechnology names. ZLAB ranks #14 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 14,200 $13,174,334
2 CRVS
Corvus Pharmaceuticals, Inc.
 637,500 $9,524,250
3 HELP
Cybin Inc.
 1,434,988 $9,485,270
4 REGN
Regeneron Pharmaceuticals, Inc.
 9,250 $5,767,745
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,500 $5,712,395
6 NAMS
NewAmsterdam Pharma Co N.V.
 141,000 $4,778,490
7 INCY
Incyte Corp
 41,500 $4,704,440
8 IMRX
Immuneering Corp
 790,000 $3,942,100

All Filings in ZLAB

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,206,500 63,500
2026-03-31 $1,194,435 63,500
2025-12-31 $1,719,900 97,500
2025-12-31 $26,460 1,500
2025-09-30 $3,117,880 92,000
2025-06-30 $3,182,270 91,000
2025-03-31 $3,252,600 90,000
2024-12-31 $1,695,802 64,750
2024-09-30 $1,019,915 42,250
2024-06-30 $527,698 30,450